Globus Medical (GMED) Tops Q3 EPS by 3c

Globus Medical (NYSE: GMED) reported Q3 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $137 million versus the consensus estimate of $127.46 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Hermès can regain momentum despite China weakness, Jefferies says